- Home
- OGI vs SCPH Comparison
OGI vs SCPH Comparison
Compare OGI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- SCPH
- Stock Information
- Founded
- OGI 2013
- SCPH 2013
- Country
- OGI Canada
- SCPH United States
- Employees
- OGI N/A
- SCPH N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- SCPH Health Care
- Exchange
- OGI Nasdaq
- SCPH Nasdaq
- Market Cap
- OGI 231.9M
- SCPH 299.0M
- IPO Year
- OGI N/A
- SCPH 2017
- Fundamental
- Price
- OGI $1.88
- SCPH $5.62
- Analyst Decision
- OGI
- SCPH Buy
- Analyst Count
- OGI 0
- SCPH 3
- Target Price
- OGI N/A
- SCPH $12.00
- AVG Volume (30 Days)
- OGI 720.7K
- SCPH 2.5M
- Earning Date
- OGI 08-13-2025
- SCPH 11-12-2025
- Dividend Yield
- OGI N/A
- SCPH N/A
- EPS Growth
- OGI N/A
- SCPH N/A
- EPS
- OGI 0.05
- SCPH N/A
- Revenue
- OGI $164,107,753.00
- SCPH $49,969,000.00
- Revenue This Year
- OGI $59.31
- SCPH $104.30
- Revenue Next Year
- OGI $15.12
- SCPH $76.06
- P/E Ratio
- OGI $37.03
- SCPH N/A
- Revenue Growth
- OGI 50.01
- SCPH 107.79
- 52 Week Low
- OGI $0.85
- SCPH $1.94
- 52 Week High
- OGI $1.95
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- OGI 74.68
- SCPH 63.32
- Support Level
- OGI $1.56
- SCPH $4.33
- Resistance Level
- OGI $1.70
- SCPH $5.62
- Average True Range (ATR)
- OGI 0.07
- SCPH 0.04
- MACD
- OGI 0.01
- SCPH -0.01
- Stochastic Oscillator
- OGI 97.44
- SCPH 80.00
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.